Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangsu Provincial Cell Center is a specialized biotechnology company and research institution focused on the industrialization of cell therapies and regenerative medicine. Based in Nanjing, China, the center operates a comprehensive infrastructure for cell storage, quality testing, and GMP-compliant manufacturing of stem cells and immune cells. Its primary business includes providing cell banking services to the public and developing a pipeline of therapeutic products, notably mesenchymal stem cells for inflammatory and degenerative conditions. The center also functions as a regional hub for cell technology standards and clinical translation in Jiangsu Province. It serves as a key platform for the integration of industry, academia, and research in the field of life sciences within the Jiangbei New Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangsu Provincial Cell Center.